Today: October 17, 2017, 6:23 am
  
Health

Antidiabetics Market Global Industry Volume - 2023

Transparency Market Research Report Added "Antidiabetics Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2015 - 2023"

 

PR-Inside.com: 2017-07-17 12:39:37
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.


The anti-diabetics market has been segmented based on type of drug class into biguanides (metformin), sulfonylureas (glimepiride), meglitinides (repaglinide), thiazolidinediones (pioglitazone), dipeptidyl peptidase IV (DPP-IV) inhibitors (sitagliptin), and α-glucosidase inhibitors (acarbose).

Obtain Report Details @

www.transparencymarketresearch.com/antidiabetics-market.html

Among these drug classes, Biguanides act directly against insulin resistance. Sulfonylureas (SUs) were the earliest drug classes in the market for treatment of diabetes and have a significant market presence. α-glucosidase inhibitors delay postprandial glucose absorption by hydrolysis of disaccharide is into monosaccharide’s in the small intestine. Meglitinides are prandial insulin releasers that stimulate rapid insulin secretion. The thiazolidinediones are insulin-sensitizing drugs, which improve whole-body insulin sensitivity through gene regulation. DPP-IV inhibitors make a significant impact on glucose tolerance and make lasting improvements in the health outcomes of diabetic patients.

Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.

Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk's diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk.

However, despite the availability of numerous branded antidiabetic drugs, many of these drugs have lost patent protection. In the wake of huge pressures from government and regulatory authorities, which have banned top selling drugs in various countries, in order to promote generic drugs at lower costs for diabetic patients. For instance, Mankind Pharma, launched anti-diabeticDynaglipt (Teneligliptin) under the drug class DPP-4 inhibitors in November 2015 in India targeting the middle to low income diabetic patient population.

As a result, the volume of antidiabetics is expected to shift to first generation drugs and other generic drugs in the market. Moreover, there is a huge unmet medical need for antidiabetics that can treat multiple chronic disorderscoexisting with diabetessuch as cardiovascular diseases, dyslipidemia, hypertension etc. Another major restraint in the antidiabetics market is reduction in the efficacy of drugs over a period and canlead to other health complications.

Some of the major players in the market include Astra Zeneca plc, Boehringer Ingelheim GmbH, Eli Lilly & Co., Johnson & Johnson, Mankind Pharma Ltd., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., and Teva Pharmaceutical Industries Ltd.

Fill the form for an exclusive sample of this report @

www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_ ..

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Press Information


Published by
Rohit Bhisey
+1-518-618-1030
e-mail
www.transparencymarketresearch.com/



# 652 Words
Related Articles
More From The Author
Nerve Monitoring Devices Market: Emerging Trends and [..]
Global Nerve Monitoring Devices Market Nerve monitoring devices are various implements used to supervise the function of the [..]
Global Outlook for Dental Wound Dressings Market [..]
Surgery in oral cavity can cause trauma to surrounding tissues and can create a wound which requires a long time [..]
Vaginitis Therapeutics Market Opportunities, Future Trends [..]
Vaginitis is a frequently occurring medical disorder in women associated with substantial morbidity and formerly undetected complications. [..]
Submarine Power Cable Market Positive Long-Term Growth [..]
A submarine power cable is an electricity transmission cable used primarily to carry electricity from below the surface of [..]
Lymphoma Treatments Market - Global Industry Volume [..]
Rise in the incidence of lymphoma throughout the globe is expected to drive the growth of lymphoma treatments market. According [..]
 
More From Health
“Reverse Abscopal Effect” in Rheumatoid Arthritis Using [..]
Biotech Holdings Announces Effective Induction of “Reverse Abscopal Effect” in Rheumatoid Arthritis Using Procell Activated Stem [..]
Air Optix Aqua Contacts from Alcon Keeps [..]
Alcon Laboratories’ Air Optix Aqua 6 pack contact lenses bring together two advanced technologies designed to provide long-lasting [..]
Simple Biomechanical Test could aid Implant Success
Tsukuba, Japan, Oct 10, 2017 - (ACN Newswire) - The quality of the tissue-implant interface is key to the success [..]
Daily Disposable Wear from Sauflon Clariti Keeps [..]
Sauflon Clariti is designed to give customers daily disposable lenses with the benefits of silicone hydrogel material and AquaGen [..]
Understanding Prescription Opioid Addiction, Riverside Clinic [..]
A recent report on ABC News says over the past decade the use of opioid-based prescription painkillers has quadrupled. Over [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.